Showing results (1441-1450 of 4,511) with videos related to

Sort By:
Pageof 452
Advances in Therapy|February 11, 2023
Genetic Evidence Supporting Causal Roles of mTOR-Dependent Proteins in Rheumatic Fever: A Two-Sample Randomized Mendelian StudyYan-Fei Mu, Qian Wang, Jing-Xi Hu, et al.
Advances in Therapy|April 29, 2006
Tau protein as a serum marker of brain damage in mild traumatic brain injury: preliminary resultsM Bulut, O Koksal, S Dogan, et al.
Advances in Therapy|April 29, 2006
Prospective comparative switch study from timolol 0.5% and latanoprost 0.005% to bimatoprost 0.03%Christopher J Brittain, Rohit Saxena, Andrew Waldock
Advances in Therapy|April 29, 2006
Antibiotic therapy for patients with spinal cord injury undergoing urologic proceduresSubramanian Vaidyanathan, Bakul M Soni
Advances in Therapy|August 17, 2006
A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucomaMonte S Dirks, Robert J Noecker, Melissa Earl, et al.
Advances in Therapy|August 17, 2006
Safety awareness among laboratory workersAysun Ozsahin, Melek Demir, Mehmet Zencir, et al.
Advances in Therapy|August 17, 2006
H-Wave, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: a preliminary statistical outcome studyKenneth Blum, Nicholas A DiNubile, Tarkan Tekten, et al.
Advances in Therapy|August 17, 2006
Metabolic syndrome and its association with ischemic cerebrovascular diseaseGulbin Aygencel, Ahmet Karamercan, Emine Akinci, et al.
Advances in Therapy|June 10, 2005
Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteersUwe Ullmann, Juergen Metzner, Thomas Frank, et al.
Advances in Therapy|March 3, 2006
Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetesMaurizio Bevilacqua, Velella Righini, Massimo Barrella, et al.
Pageof 452